Cogent Biosciences
COGT
COGT
87 hedge funds and large institutions have $349M invested in Cogent Biosciences in 2022 Q1 according to their latest regulatory filings, with 16 funds opening new positions, 18 increasing their positions, 30 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less ownership
Funds ownership: →
29% less funds holding in top 10
Funds holding in top 10: 7 → 5 (-2)
40% less repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 30
Holders
87
Holding in Top 10
5
Calls
$3K
Puts
–
Top Buyers
| 1 | +$9.13M | |
| 2 | +$5.33M | |
| 3 | +$4.87M | |
| 4 |
EAM
Eventide Asset Management
Boston,
Massachusetts
|
+$2.88M |
| 5 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$1.87M |
Top Sellers
| 1 | -$15.2M | |
| 2 | -$8.8M | |
| 3 | -$1.57M | |
| 4 |
ABG
Ally Bridge Group
New York
|
-$1.44M |
| 5 |
KCM
Kynam Capital Management
Princeton,
New Jersey
|
-$1.29M |